ripekg:evaluation/RIPEAE59AF25CB9D16527 |
prov:used |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
rdfs:Resource |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
owl:Thing |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
ripe:RegistryEvidenceRegistry evidence |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
tido:Evidence |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
prov:wasAttributedTo |
ripekg:source/who-ictrpWHO ICTRP |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
prov:wasAttributedTo |
ripekg:source/who-ictrpWHO International Clinical Trials Registry Platform |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAE59AF25CB9D16527 |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAE59AF25CB9D16527 |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
ripe:concerns |
ripekg:work/10.1111%2Fpai.12978EXPRESSION OF CONCERN: The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double‐blinded, placebo‐controlled trial |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
ripe:isProspective |
true |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
ripe:registrationAssessmentRationale |
Comparison performed at month level. Registration: 2017-10, LLM Recruitment Start: 2017-11. Deemed prospective at month level. |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
ripe:registrationDate |
2017-10-15 |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
ripe:registrationId |
IRCT2017082733941N12 |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
ripe:registrationLink |
https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT2017082733941N12 |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
ripe:registryName |
IRCT |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-human-2-2 |
ripekg:registry-evidence/RIPEAE59AF25CB9D16527 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-2-2 |